Insider · CIK 0001832694
Papapetropoulos Spyros
Reports to the SEC for 4 companies · BURLINGTON, MA
Transactions
22
Companies
4
Filings
15
CIK
0001832694
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-08-27 | NEUPNeuphoria Therapeutics Inc. · Employee Stock Option (Right-to- Buy)A Award | +$286K |
| 2025-06-04 | LPCNLipocine Inc. · Stock Option (Right to Buy)A Award | +$5,644.8 |
| 2025-04-16 | NEUPNeuphoria Therapeutics Inc. · Employee Stock Option (Right-to-Buy)A Award | +$1.39M |
| 2025-04-16 | NEUPNeuphoria Therapeutics Inc. · Employee Stock Option (Right-to-Buy)A Award | +$139K |
| 2024-06-05 | LPCNLipocine Inc. · Stock Option (Right to Buy)A Award | +$12.4K |
| 2023-05-10 | LPCNLipocine Inc. · Stock Option (Right to Buy)A Award | +$7,968 |
| 2022-11-22 | LPCNLipocine Inc.P Purchase | +$10.2K |
| 2022-11-18 | Vigil Neuroscience, Inc.M Exercise/Conversion | +$567 |
| 2022-11-18 | Vigil Neuroscience, Inc.S Sale | −$4,200 |
| 2022-11-18 | Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)M Exercise/Conversion | — |
| 2022-06-08 | LPCNLipocine Inc. · Stock Option (Right to Buy)A Award | +$20.2K |
| 2022-05-03 | Vigil Neuroscience, Inc.P Purchase | +$13.6K |
| 2022-04-11 | LPCNLipocine Inc. · Stock Option (Right to Buy)A Award | +$11.6K |
| 2022-03-01 | Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award | — |
| 2021-11-24 | Adamas Pharmaceuticals IncU Disposition from Tender | — |
| 2021-11-24 | Adamas Pharmaceuticals IncStock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-11-24 | Adamas Pharmaceuticals IncStock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-06-02 | Adamas Pharmaceuticals IncA Award | — |
| 2021-06-02 | Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award | — |
| 2021-03-11 | Adamas Pharmaceuticals IncP Purchase | +$30.2K |
| 2020-11-22 | Adamas Pharmaceuticals IncA Award | — |
| 2020-11-22 | Adamas Pharmaceuticals IncStock Option (Rightto Buy)A Award | — |
Recent filings
- 4Papapetropoulos Spyros0001213900-25-082904SEC(opens sec.gov)
- 4Papapetropoulos Spyros0001641172-25-013797SEC(opens sec.gov)
- 4/APapapetropoulos Spyros0001213900-25-045445SEC(opens sec.gov)
- 4Papapetropoulos Spyros0001213900-25-033144SEC(opens sec.gov)
- 4Papapetropoulos Spyros0001493152-24-023215SEC(opens sec.gov)
- 4Papapetropoulos Spyros0001493152-23-016695SEC(opens sec.gov)
- 4Papapetropoulos Spyros0001493152-22-033841SEC(opens sec.gov)
- 4Papapetropoulos Spyros0000899243-22-036831SEC(opens sec.gov)
- 4Papapetropoulos Spyros0001493152-22-016402SEC(opens sec.gov)
- 4Papapetropoulos Spyros0000899243-22-016530SEC(opens sec.gov)
- 4Papapetropoulos Spyros0001493152-22-009718SEC(opens sec.gov)
- 4Papapetropoulos Spyridon0000899243-22-009052SEC(opens sec.gov)
- 4Papapetropoulos Spyridon0001328143-21-000089SEC(opens sec.gov)
- 4Papapetropoulos Spyridon0001328143-21-000060SEC(opens sec.gov)
- 4Papapetropoulos Spyridon0001209191-21-020418SEC(opens sec.gov)
Companies
Address
100 SUMMIT DRIVE
BURLINGTON, MA, 01803